Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38&agr; MAP Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy
Bhashyam S, Fields AV, Patterson B, Testani JM, Chen L, Shen YT, Shannon RP. Glucagon-Like Peptide-1 Increases Myocardial Glucose Uptake via p38&agr; MAP Kinase-Mediated, Nitric Oxide-Dependent Mechanisms in Conscious Dogs With Dilated Cardiomyopathy. Circulation Heart Failure 2010, 3: 512-521. PMID: 20466848, PMCID: PMC3075465, DOI: 10.1161/circheartfailure.109.900282.Peer-Reviewed Original ResearchAnalysis of VarianceAnimalsBlood GlucoseCardiomyopathy, DilatedConsciousnessDisease Models, AnimalDogsFemaleGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorGlucose Transporter Type 4HemodynamicsMaleMitochondria, HeartMyocardiumNitric Oxide SynthaseP38 Mitogen-Activated Protein KinasesProbabilityRandom AllocationReceptors, GlucagonSignal TransductionVentricular Function, Left